Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Nutrinia Ltd.
DescriptionOral insulin powder formulated with excipients approved for pre-term infant consumption to target the GI tract without systemic exposure
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationShort bowel syndrome
Indication DetailsTreat short bowel syndrome (SBS); Treat short bowel syndrome following surgical resection
Regulatory Designation U.S. - Orphan Drug (Treat short bowel syndrome (SBS))

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today